PMC:7074432 / 4040-4539 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"169","span":{"begin":188,"end":193},"obj":"Gene"},{"id":"170","span":{"begin":312,"end":317},"obj":"Gene"},{"id":"171","span":{"begin":382,"end":387},"obj":"Gene"},{"id":"173","span":{"begin":96,"end":104},"obj":"Species"},{"id":"174","span":{"begin":105,"end":113},"obj":"Species"},{"id":"175","span":{"begin":485,"end":494},"obj":"Species"},{"id":"176","span":{"begin":127,"end":136},"obj":"Chemical"},{"id":"177","span":{"begin":430,"end":436},"obj":"Chemical"},{"id":"179","span":{"begin":80,"end":91},"obj":"Disease"}],"attributes":[{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"Gene:3439"},{"id":"A170","pred":"tao:has_database_id","subj":"170","obj":"Gene:3439"},{"id":"A171","pred":"tao:has_database_id","subj":"171","obj":"Gene:3439"},{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"Tax:694009"},{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"Tax:9606"},{"id":"A175","pred":"tao:has_database_id","subj":"175","obj":"Tax:2697049"},{"id":"A176","pred":"tao:has_database_id","subj":"176","obj":"MESH:D012254"},{"id":"A177","pred":"tao:has_database_id","subj":"177","obj":"MESH:D010100"},{"id":"A179","pred":"tao:has_database_id","subj":"179","obj":"MESH:D006509"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T180","span":{"begin":96,"end":104},"obj":"SP_10"},{"id":"T179","span":{"begin":127,"end":136},"obj":"DG_29"},{"id":"T178","span":{"begin":206,"end":220},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T177","span":{"begin":322,"end":336},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T176","span":{"begin":338,"end":352},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T175","span":{"begin":365,"end":379},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T174","span":{"begin":485,"end":494},"obj":"SP_7"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":353,"end":356},"obj":"Body_part"},{"id":"T5","span":{"begin":388,"end":391},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma24890"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma24890"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":353,"end":356},"obj":"Body_part"},{"id":"T2","span":{"begin":388,"end":391},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001460"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001460"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T19","span":{"begin":80,"end":91},"obj":"Disease"},{"id":"T20","span":{"begin":80,"end":89},"obj":"Disease"},{"id":"T21","span":{"begin":96,"end":104},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T18","span":{"begin":90,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T19","span":{"begin":353,"end":356},"obj":"http://www.ebi.ac.uk/efo/EFO_0001410"},{"id":"T20","span":{"begin":388,"end":391},"obj":"http://www.ebi.ac.uk/efo/EFO_0001410"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T47","span":{"begin":33,"end":43},"obj":"Chemical"},{"id":"T48","span":{"begin":127,"end":136},"obj":"Chemical"},{"id":"T49","span":{"begin":140,"end":150},"obj":"Chemical"},{"id":"T50","span":{"begin":152,"end":155},"obj":"Chemical"},{"id":"T51","span":{"begin":188,"end":191},"obj":"Chemical"},{"id":"T52","span":{"begin":206,"end":220},"obj":"Chemical"},{"id":"T53","span":{"begin":221,"end":226},"obj":"Chemical"},{"id":"T54","span":{"begin":312,"end":315},"obj":"Chemical"},{"id":"T55","span":{"begin":322,"end":336},"obj":"Chemical"},{"id":"T56","span":{"begin":338,"end":352},"obj":"Chemical"},{"id":"T57","span":{"begin":365,"end":379},"obj":"Chemical"},{"id":"T58","span":{"begin":382,"end":385},"obj":"Chemical"},{"id":"T59","span":{"begin":430,"end":436},"obj":"Chemical"}],"attributes":[{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"},{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A51","pred":"chebi_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A59","pred":"chebi_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":80,"end":89},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}

{"project":"2_test","denotations":[{"id":"32201439-12867568-47219416","span":{"begin":228,"end":230},"obj":"12867568"},{"id":"32201439-14693875-47219417","span":{"begin":460,"end":462},"obj":"14693875"},{"id":"T43328","span":{"begin":228,"end":230},"obj":"12867568"},{"id":"T72085","span":{"begin":460,"end":462},"obj":"14693875"}],"text":"ferons (IFNs) are broad-spectrum antivirals, primarily used in the treatment of hepatitis B. In SARS-CoV patients, compared to ribavirin or interferon (IFN) alone, the benefit was seen on IFN-α + high-dose corticosteroid group.[20] Other observational studies also support these findings and the combined use of IFN-α and corticosteroid (corticosteroid arm n = 13; corticosteroid + IFN-α arm n = 9) showed less disease-associated oxygen saturation impairment.[21] For the treatment of 2019-nCoV (7),"}